Expanding the treatment of chronic hepatitis B
10.3969/j.issn.1001-5256.2023.01.001
- VernacularTitle:扩大慢性乙型肝炎治疗
- Author:
Hui ZHUANG
1
Author Information
1. Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing 100191, China
- Publication Type:Editorial
- Keywords:
Hepatitis B, Chronic;
Hepatitis B Vaccine;
Therapeutics
- From:
Journal of Clinical Hepatology
2023;39(1):10-13
- CountryChina
- Language:Chinese
-
Abstract:
Among chronic hepatitis B patients eligible for treatment, only 5% have received antiviral therapy worldwide. The strictness of treatment criteria in current guidelines is one of the contributing factors for the low treatment rate of patients with chronic hepatitis B, and expanding the treatment criteria for chronic hepatitis B established in current guidelines may reduce disease burden. Universal hepatitis B vaccination, universal screening, and treatment of all HBV DNA-positive patients will help to achieve the goal of HBV elimination by 2030 proposed by the World Health Organization.
